| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Notch1 | 75 | 2017 | 521 | 6.150 |
Why?
|
| Receptors, Notch | 54 | 2017 | 752 | 4.990 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 29 | 2017 | 384 | 3.510 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 17 | 2010 | 167 | 2.380 |
Why?
|
| Signal Transduction | 90 | 2017 | 23638 | 1.540 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 19 | 2017 | 133 | 1.400 |
Why?
|
| Gene Expression Regulation, Leukemic | 11 | 2017 | 656 | 1.270 |
Why?
|
| Receptors, Cell Surface | 28 | 2004 | 2819 | 1.260 |
Why?
|
| Membrane Proteins | 48 | 2015 | 7895 | 1.040 |
Why?
|
| Transcriptional Activation | 16 | 2011 | 1751 | 1.020 |
Why?
|
| Transcription Factors | 49 | 2017 | 12174 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-myc | 12 | 2017 | 998 | 0.870 |
Why?
|
| Leukemia, T-Cell | 6 | 2011 | 101 | 0.840 |
Why?
|
| Enhancer Elements, Genetic | 7 | 2017 | 1368 | 0.830 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 2017 | 264 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2017 | 8635 | 0.680 |
Why?
|
| Cell Transformation, Neoplastic | 16 | 2014 | 2847 | 0.620 |
Why?
|
| Ankyrin Repeat | 3 | 2011 | 19 | 0.610 |
Why?
|
| Mutation | 47 | 2019 | 30243 | 0.610 |
Why?
|
| Oncogene Proteins, Fusion | 16 | 2016 | 1614 | 0.590 |
Why?
|
| Drug Resistance, Neoplasm | 11 | 2018 | 5342 | 0.580 |
Why?
|
| Response Elements | 4 | 2017 | 308 | 0.570 |
Why?
|
| Translocation, Genetic | 15 | 2016 | 1395 | 0.560 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 12 | 2016 | 1427 | 0.560 |
Why?
|
| Nuclear Proteins | 24 | 2016 | 5808 | 0.560 |
Why?
|
| Neoplasm Proteins | 12 | 2016 | 3611 | 0.550 |
Why?
|
| Protein Structure, Tertiary | 24 | 2014 | 3790 | 0.510 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2014 | 1557 | 0.510 |
Why?
|
| Promoter Regions, Genetic | 16 | 2017 | 5803 | 0.470 |
Why?
|
| Amyloid Precursor Protein Secretases | 12 | 2017 | 619 | 0.460 |
Why?
|
| Phenothiazines | 2 | 2014 | 61 | 0.460 |
Why?
|
| DNA-Binding Proteins | 32 | 2012 | 9623 | 0.440 |
Why?
|
| Animals | 130 | 2019 | 169418 | 0.440 |
Why?
|
| Ribonuclease III | 1 | 2015 | 270 | 0.430 |
Why?
|
| Genome, Human | 3 | 2017 | 4453 | 0.430 |
Why?
|
| Bone Marrow Transplantation | 14 | 2011 | 2702 | 0.430 |
Why?
|
| Cell Line, Tumor | 36 | 2017 | 17149 | 0.430 |
Why?
|
| Oncogenes | 9 | 2017 | 1235 | 0.430 |
Why?
|
| Hematopoietic Stem Cells | 19 | 2017 | 3408 | 0.430 |
Why?
|
| T-Lymphocytes | 24 | 2014 | 10273 | 0.420 |
Why?
|
| Receptor, Notch2 | 8 | 2014 | 90 | 0.420 |
Why?
|
| Oncogene Proteins | 5 | 2011 | 718 | 0.410 |
Why?
|
| Mice | 91 | 2019 | 82045 | 0.410 |
Why?
|
| B-Lymphocytes | 18 | 2017 | 4781 | 0.410 |
Why?
|
| Transcription, Genetic | 14 | 2016 | 7599 | 0.410 |
Why?
|
| Leukemia | 10 | 2017 | 1527 | 0.400 |
Why?
|
| Protein Phosphatase 2 | 1 | 2014 | 231 | 0.390 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 164 | 0.390 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 11 | 2015 | 1660 | 0.380 |
Why?
|
| Neoplasms | 16 | 2018 | 22386 | 0.380 |
Why?
|
| Immune System Diseases | 1 | 2014 | 255 | 0.380 |
Why?
|
| Gene Expression Regulation | 9 | 2015 | 11930 | 0.370 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2010 | 430 | 0.350 |
Why?
|
| Cell Proliferation | 19 | 2017 | 10494 | 0.350 |
Why?
|
| Antineoplastic Agents | 10 | 2017 | 13708 | 0.350 |
Why?
|
| Lymphoma, B-Cell | 10 | 2017 | 945 | 0.350 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2010 | 100 | 0.340 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 1152 | 0.340 |
Why?
|
| Lymphoma, T-Cell | 6 | 2008 | 304 | 0.330 |
Why?
|
| Antibodies | 4 | 2015 | 2425 | 0.320 |
Why?
|
| Cell Differentiation | 26 | 2017 | 11674 | 0.320 |
Why?
|
| Apoptosis | 12 | 2015 | 9526 | 0.320 |
Why?
|
| Conserved Sequence | 4 | 2010 | 1164 | 0.310 |
Why?
|
| RNA-Binding Proteins | 2 | 2015 | 1885 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2006 | 247 | 0.300 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2006 | 286 | 0.300 |
Why?
|
| Herpesviridae Infections | 4 | 2006 | 269 | 0.300 |
Why?
|
| Humans | 201 | 2019 | 768451 | 0.300 |
Why?
|
| Multiprotein Complexes | 2 | 2013 | 1112 | 0.300 |
Why?
|
| Hematologic Neoplasms | 4 | 2016 | 1905 | 0.290 |
Why?
|
| Cyclins | 3 | 2008 | 606 | 0.290 |
Why?
|
| Molecular Sequence Data | 26 | 2014 | 17647 | 0.290 |
Why?
|
| Luciferases | 7 | 2014 | 712 | 0.280 |
Why?
|
| Cell Lineage | 15 | 2017 | 2575 | 0.280 |
Why?
|
| Lymphoma | 7 | 2016 | 1907 | 0.280 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2011 | 792 | 0.280 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 1357 | 0.280 |
Why?
|
| Gene Expression Profiling | 19 | 2018 | 9507 | 0.270 |
Why?
|
| Endopeptidases | 7 | 2007 | 772 | 0.260 |
Why?
|
| Myeloproliferative Disorders | 7 | 2017 | 614 | 0.260 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2008 | 171 | 0.260 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2015 | 2882 | 0.260 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2015 | 2434 | 0.250 |
Why?
|
| Down-Regulation | 6 | 2014 | 2944 | 0.240 |
Why?
|
| Dimerization | 9 | 2010 | 888 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6135 | 0.240 |
Why?
|
| Amino Acid Sequence | 19 | 2017 | 13452 | 0.240 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2017 | 2525 | 0.240 |
Why?
|
| Plasmids | 7 | 2014 | 2269 | 0.240 |
Why?
|
| Homeodomain Proteins | 6 | 2012 | 2430 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2017 | 32 | 0.230 |
Why?
|
| Lymphocytes | 6 | 2006 | 2611 | 0.230 |
Why?
|
| Herpesvirus 4, Human | 7 | 2011 | 1081 | 0.230 |
Why?
|
| Genes, myc | 4 | 2014 | 391 | 0.220 |
Why?
|
| Blotting, Western | 14 | 2016 | 5042 | 0.220 |
Why?
|
| Mediastinal Neoplasms | 4 | 2011 | 403 | 0.220 |
Why?
|
| Oncogene Protein v-akt | 2 | 2015 | 130 | 0.220 |
Why?
|
| Sequence Deletion | 8 | 2013 | 1497 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2015 | 4586 | 0.220 |
Why?
|
| Lens, Crystalline | 5 | 1986 | 387 | 0.220 |
Why?
|
| Protease Inhibitors | 4 | 2014 | 753 | 0.220 |
Why?
|
| Bone Marrow | 5 | 2010 | 2929 | 0.220 |
Why?
|
| Lymphoma, Non-Hodgkin | 6 | 2010 | 1376 | 0.210 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 4 | 2011 | 158 | 0.210 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2915 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2016 | 1409 | 0.210 |
Why?
|
| Genes, bcl-2 | 2 | 2007 | 119 | 0.210 |
Why?
|
| Cell Line | 23 | 2015 | 15609 | 0.210 |
Why?
|
| Transfection | 15 | 2015 | 5767 | 0.210 |
Why?
|
| Trans-Activators | 14 | 2013 | 2858 | 0.210 |
Why?
|
| Hematopoiesis | 8 | 2017 | 2058 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2015 | 3805 | 0.200 |
Why?
|
| Base Sequence | 13 | 2016 | 12428 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 8 | 2018 | 5709 | 0.200 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11138 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2017 | 3619 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 12 | 2015 | 1085 | 0.190 |
Why?
|
| Testicular Neoplasms | 1 | 2007 | 806 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2010 | 3697 | 0.190 |
Why?
|
| Genes, Immunoglobulin | 1 | 2002 | 286 | 0.190 |
Why?
|
| Protein Binding | 14 | 2017 | 9376 | 0.180 |
Why?
|
| Disease Models, Animal | 17 | 2019 | 18388 | 0.180 |
Why?
|
| Gene Rearrangement | 6 | 2017 | 1139 | 0.180 |
Why?
|
| Thymus Gland | 9 | 2011 | 1267 | 0.180 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2002 | 168 | 0.180 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2011 | 2751 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 13 | 2009 | 3735 | 0.180 |
Why?
|
| Repressor Proteins | 8 | 2013 | 2987 | 0.180 |
Why?
|
| Hodgkin Disease | 4 | 2005 | 1386 | 0.170 |
Why?
|
| Antibody Specificity | 5 | 2013 | 1065 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 4 | 2009 | 531 | 0.170 |
Why?
|
| Peptides | 6 | 2011 | 4368 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 8 | 2016 | 9263 | 0.170 |
Why?
|
| Protein Biosynthesis | 2 | 2004 | 2096 | 0.170 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 2 | 2010 | 86 | 0.170 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2016 | 230 | 0.170 |
Why?
|
| Cells, Cultured | 19 | 2015 | 19041 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 9 | 5 | 2008 | 534 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 5 | 2000 | 1337 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-rel | 5 | 2006 | 71 | 0.170 |
Why?
|
| Binding Sites | 10 | 2013 | 6030 | 0.170 |
Why?
|
| Carcinoma | 2 | 2009 | 2341 | 0.170 |
Why?
|
| Blood Proteins | 4 | 1986 | 1183 | 0.160 |
Why?
|
| Lymphoma, Follicular | 2 | 2002 | 460 | 0.160 |
Why?
|
| Genetic Variation | 3 | 2016 | 6610 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 4 | 2011 | 616 | 0.160 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2019 | 3623 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2007 | 361 | 0.160 |
Why?
|
| Chromosome Aberrations | 7 | 2016 | 1781 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 8 | 2014 | 4083 | 0.160 |
Why?
|
| Neuropeptides | 4 | 1986 | 950 | 0.160 |
Why?
|
| Isoquinolines | 2 | 2017 | 354 | 0.160 |
Why?
|
| Ikaros Transcription Factor | 2 | 2010 | 233 | 0.160 |
Why?
|
| Ligands | 13 | 2015 | 3281 | 0.160 |
Why?
|
| Blotting, Southern | 6 | 2010 | 777 | 0.160 |
Why?
|
| Models, Biological | 14 | 2017 | 9505 | 0.150 |
Why?
|
| Sulfonamides | 4 | 2016 | 1988 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2012 | 4534 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 1999 | 172 | 0.150 |
Why?
|
| Burkitt Lymphoma | 1 | 2000 | 336 | 0.150 |
Why?
|
| Cell Cycle Proteins | 8 | 2014 | 3463 | 0.150 |
Why?
|
| Calcium | 7 | 2003 | 5793 | 0.150 |
Why?
|
| Aspartic Acid Endopeptidases | 6 | 2005 | 309 | 0.150 |
Why?
|
| Cell Cycle | 8 | 2016 | 2942 | 0.150 |
Why?
|
| Phosphorylation | 10 | 2014 | 8332 | 0.150 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2010 | 236 | 0.150 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2018 | 720 | 0.150 |
Why?
|
| Blotting, Northern | 3 | 2010 | 1553 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2014 | 664 | 0.140 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 249 | 0.140 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 2 | 2017 | 212 | 0.140 |
Why?
|
| Chromatin | 5 | 2016 | 2969 | 0.140 |
Why?
|
| Transduction, Genetic | 4 | 2011 | 903 | 0.140 |
Why?
|
| Mice, Transgenic | 15 | 2019 | 9558 | 0.140 |
Why?
|
| Models, Molecular | 12 | 2016 | 5443 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2014 | 856 | 0.140 |
Why?
|
| Point Mutation | 6 | 2009 | 1596 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2015 | 3612 | 0.130 |
Why?
|
| Herpesvirus 8, Human | 1 | 1998 | 256 | 0.130 |
Why?
|
| Animals, Genetically Modified | 5 | 2015 | 1563 | 0.130 |
Why?
|
| 3T3 Cells | 8 | 2012 | 1086 | 0.130 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.130 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2016 | 82 | 0.130 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 126 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 8 | 2011 | 1143 | 0.130 |
Why?
|
| Tretinoin | 1 | 2019 | 525 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2014 | 1056 | 0.130 |
Why?
|
| Genes, Reporter | 7 | 2014 | 1525 | 0.130 |
Why?
|
| DNA Primers | 3 | 2013 | 2826 | 0.130 |
Why?
|
| Retroviridae | 7 | 2003 | 850 | 0.120 |
Why?
|
| Megakaryocytes | 2 | 2011 | 575 | 0.120 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 3 | 2016 | 497 | 0.120 |
Why?
|
| Protein Kinase C | 2 | 2012 | 1207 | 0.120 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2015 | 86 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 1 | 1998 | 374 | 0.120 |
Why?
|
| Mutation, Missense | 4 | 2016 | 2594 | 0.120 |
Why?
|
| Cyclin C | 1 | 2014 | 12 | 0.120 |
Why?
|
| Crystallins | 2 | 1985 | 75 | 0.120 |
Why?
|
| Saphenous Vein | 2 | 2015 | 519 | 0.120 |
Why?
|
| Clone Cells | 7 | 2017 | 1672 | 0.120 |
Why?
|
| Milk Proteins | 3 | 2000 | 162 | 0.120 |
Why?
|
| Spectrin | 2 | 1986 | 176 | 0.120 |
Why?
|
| Neointima | 1 | 2015 | 133 | 0.120 |
Why?
|
| Macaca mulatta | 4 | 2006 | 2363 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2015 | 86 | 0.120 |
Why?
|
| Protein Conformation | 5 | 2016 | 3973 | 0.120 |
Why?
|
| Drosophila | 5 | 2013 | 1514 | 0.120 |
Why?
|
| Flow Cytometry | 11 | 2016 | 5904 | 0.120 |
Why?
|
| Lymphocryptovirus | 2 | 2004 | 14 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 333 | 0.120 |
Why?
|
| HEK293 Cells | 8 | 2015 | 4294 | 0.120 |
Why?
|
| Renilla | 1 | 2014 | 6 | 0.120 |
Why?
|
| Skin Neoplasms | 4 | 2017 | 5891 | 0.120 |
Why?
|
| Genes, Essential | 1 | 2015 | 185 | 0.120 |
Why?
|
| Cell Survival | 6 | 2017 | 5801 | 0.120 |
Why?
|
| Perphenazine | 1 | 2014 | 33 | 0.120 |
Why?
|
| Zebrafish | 7 | 2015 | 3038 | 0.110 |
Why?
|
| Purines | 1 | 2017 | 614 | 0.110 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2013 | 41 | 0.110 |
Why?
|
| Valine | 1 | 2015 | 410 | 0.110 |
Why?
|
| Neoplasm Transplantation | 8 | 2016 | 2017 | 0.110 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 306 | 0.110 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1996 | 94 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2017 | 3665 | 0.110 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 8 | 2011 | 2072 | 0.110 |
Why?
|
| Pigmentation | 1 | 2014 | 143 | 0.110 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 906 | 0.110 |
Why?
|
| Copper Radioisotopes | 1 | 2013 | 100 | 0.110 |
Why?
|
| Erythrocyte Membrane | 6 | 1984 | 438 | 0.110 |
Why?
|
| Alleles | 7 | 2016 | 6890 | 0.110 |
Why?
|
| Recombinant Proteins | 8 | 2011 | 6527 | 0.110 |
Why?
|
| Enzyme Assays | 1 | 2014 | 104 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 414 | 0.110 |
Why?
|
| Genetic Techniques | 3 | 2002 | 428 | 0.100 |
Why?
|
| Dopamine Antagonists | 1 | 2014 | 289 | 0.100 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2019 | 954 | 0.100 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 525 | 0.100 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 57 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2016 | 1094 | 0.100 |
Why?
|
| Multigene Family | 2 | 2007 | 1081 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2010 | 5192 | 0.100 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1992 | 37 | 0.100 |
Why?
|
| Biophysical Phenomena | 2 | 2011 | 321 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 16 | 2019 | 22365 | 0.100 |
Why?
|
| Betapapillomavirus | 1 | 2012 | 15 | 0.100 |
Why?
|
| Indazoles | 1 | 2014 | 306 | 0.100 |
Why?
|
| Carrier Proteins | 8 | 2003 | 4948 | 0.100 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2013 | 132 | 0.100 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4120 | 0.100 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2010 | 687 | 0.100 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 463 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 875 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 8 | 2 | 2014 | 49 | 0.100 |
Why?
|
| Immunity | 2 | 2016 | 1002 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2007 | 714 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2012 | 357 | 0.100 |
Why?
|
| Cell Nucleus | 5 | 2007 | 2889 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2009 | 190 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2012 | 1119 | 0.100 |
Why?
|
| Cell Line, Transformed | 5 | 2006 | 868 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2017 | 6537 | 0.090 |
Why?
|
| Glycolysis | 1 | 2015 | 838 | 0.090 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2011 | 72 | 0.090 |
Why?
|
| Structure-Activity Relationship | 4 | 2011 | 3073 | 0.090 |
Why?
|
| RNA, Messenger | 9 | 2014 | 12813 | 0.090 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 136 | 0.090 |
Why?
|
| Mice, Knockout | 9 | 2015 | 14480 | 0.090 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1992 | 420 | 0.090 |
Why?
|
| Metalloproteins | 1 | 2011 | 98 | 0.090 |
Why?
|
| Organ Culture Techniques | 2 | 2011 | 796 | 0.090 |
Why?
|
| Gene Duplication | 2 | 2016 | 314 | 0.090 |
Why?
|
| Lymphoid Tissue | 1 | 1992 | 446 | 0.090 |
Why?
|
| Enzyme Inhibitors | 5 | 2014 | 3734 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2019 | 11843 | 0.090 |
Why?
|
| Male | 42 | 2017 | 364781 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2012 | 342 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2015 | 1019 | 0.090 |
Why?
|
| Immunophenotyping | 5 | 2016 | 1869 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2005 | 1628 | 0.090 |
Why?
|
| Leukemia, Myeloid | 3 | 2006 | 693 | 0.090 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2011 | 175 | 0.090 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2013 | 91 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10784 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 4 | 2016 | 2834 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2016 | 2819 | 0.090 |
Why?
|
| Benzylidene Compounds | 1 | 2009 | 25 | 0.080 |
Why?
|
| Proteins | 6 | 2004 | 6008 | 0.080 |
Why?
|
| Mice, SCID | 5 | 2016 | 2633 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2013 | 2562 | 0.080 |
Why?
|
| Macrophages | 5 | 2015 | 5797 | 0.080 |
Why?
|
| Vestibular Diseases | 2 | 2003 | 232 | 0.080 |
Why?
|
| Protein Multimerization | 2 | 2015 | 980 | 0.080 |
Why?
|
| Cancer Vaccines | 1 | 2017 | 1044 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2884 | 0.080 |
Why?
|
| Protein Kinases | 4 | 2016 | 1608 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2008 | 387 | 0.080 |
Why?
|
| F-Box Proteins | 1 | 2011 | 201 | 0.080 |
Why?
|
| Melanoma | 3 | 2017 | 5740 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 2003 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2204 | 0.080 |
Why?
|
| Transplantation, Autologous | 4 | 2010 | 2126 | 0.080 |
Why?
|
| Cell Communication | 3 | 2015 | 1662 | 0.080 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2010 | 121 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 4931 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2011 | 384 | 0.080 |
Why?
|
| Receptors, Cytokine | 1 | 2009 | 257 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 8 | 2014 | 6241 | 0.080 |
Why?
|
| Antigens, Viral | 3 | 2010 | 992 | 0.080 |
Why?
|
| Janus Kinase 3 | 1 | 2009 | 77 | 0.080 |
Why?
|
| Janus Kinase 2 | 2 | 2009 | 561 | 0.080 |
Why?
|
| Leukemia, Experimental | 2 | 2016 | 225 | 0.080 |
Why?
|
| Bone Marrow Cells | 9 | 2012 | 2415 | 0.080 |
Why?
|
| Mammary Glands, Human | 1 | 2010 | 202 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 1998 | 453 | 0.080 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2008 | 26 | 0.080 |
Why?
|
| Receptors, Fibroblast Growth Factor | 2 | 2000 | 196 | 0.080 |
Why?
|
| Cyclin D3 | 2 | 2008 | 54 | 0.080 |
Why?
|
| Crystallography, X-Ray | 5 | 2015 | 1987 | 0.080 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2011 | 290 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2015 | 2910 | 0.080 |
Why?
|
| Histones | 6 | 2016 | 2595 | 0.080 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1669 | 0.080 |
Why?
|
| Presenilin-1 | 5 | 2004 | 669 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 1 | 2 | 2005 | 48 | 0.080 |
Why?
|
| Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
| Protein Structure, Quaternary | 2 | 2006 | 429 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1766 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2017 | 9425 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2015 | 3050 | 0.070 |
Why?
|
| Interferon Regulatory Factors | 1 | 2009 | 268 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15638 | 0.070 |
Why?
|
| Histiocytosis, Sinus | 1 | 2008 | 44 | 0.070 |
Why?
|
| Serpins | 1 | 2009 | 247 | 0.070 |
Why?
|
| Remission Induction | 3 | 2010 | 2408 | 0.070 |
Why?
|
| Female | 46 | 2017 | 396943 | 0.070 |
Why?
|
| Base Pairing | 1 | 2008 | 139 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 1990 | 383 | 0.070 |
Why?
|
| Drosophila Proteins | 5 | 2011 | 1712 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2450 | 0.070 |
Why?
|
| Proteomics | 4 | 2017 | 3901 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2010 | 1400 | 0.070 |
Why?
|
| Indoles | 3 | 2014 | 1834 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1615 | 0.070 |
Why?
|
| Drug Synergism | 3 | 2017 | 1765 | 0.070 |
Why?
|
| Luminescent Proteins | 4 | 2003 | 839 | 0.070 |
Why?
|
| Oncogenic Viruses | 2 | 2004 | 37 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 3437 | 0.070 |
Why?
|
| Viral Proteins | 3 | 2011 | 1803 | 0.070 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2011 | 480 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1755 | 0.070 |
Why?
|
| Aged, 80 and over | 11 | 2017 | 59680 | 0.070 |
Why?
|
| Disease Susceptibility | 3 | 2016 | 1797 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2011 | 1905 | 0.070 |
Why?
|
| Proviruses | 2 | 2006 | 320 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2011 | 2964 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2016 | 1839 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2006 | 46 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 462 | 0.070 |
Why?
|
| Neprilysin | 1 | 2009 | 487 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 178 | 0.070 |
Why?
|
| Cisplatin | 1 | 2012 | 1661 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1010 | 0.070 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2003 | 783 | 0.070 |
Why?
|
| Rhadinovirus | 1 | 2006 | 37 | 0.070 |
Why?
|
| Frameshift Mutation | 2 | 2006 | 393 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2016 | 2757 | 0.070 |
Why?
|
| Genes, Dominant | 3 | 2008 | 856 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1998 | 192 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2007 | 3090 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 222 | 0.060 |
Why?
|
| Cell Division | 5 | 2009 | 4479 | 0.060 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2015 | 1077 | 0.060 |
Why?
|
| Computational Biology | 1 | 2018 | 3546 | 0.060 |
Why?
|
| U937 Cells | 2 | 2019 | 260 | 0.060 |
Why?
|
| Phenotype | 5 | 2017 | 16712 | 0.060 |
Why?
|
| Time Factors | 9 | 2015 | 40271 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 1625 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2008 | 352 | 0.060 |
Why?
|
| NF-kappa B | 4 | 2008 | 2491 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2006 | 1064 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 816 | 0.060 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1644 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2006 | 210 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2005 | 82 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 2006 | 11206 | 0.060 |
Why?
|
| Eosinophilia | 2 | 2003 | 558 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 223 | 0.060 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 193 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 4906 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 13026 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2008 | 564 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2006 | 594 | 0.060 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 669 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 1998 | 3291 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2150 | 0.060 |
Why?
|
| Middle Aged | 21 | 2017 | 223418 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2015 | 2024 | 0.060 |
Why?
|
| Mitosis | 2 | 2007 | 1191 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 912 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2006 | 2674 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1992 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2004 | 350 | 0.060 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2004 | 81 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2004 | 943 | 0.060 |
Why?
|
| RNA Interference | 4 | 2015 | 2832 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1990 | 798 | 0.060 |
Why?
|
| Cell Movement | 3 | 2015 | 5223 | 0.060 |
Why?
|
| Tissue Distribution | 4 | 2017 | 2298 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 2731 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2003 | 1969 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 15460 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 4419 | 0.050 |
Why?
|
| Child | 9 | 2017 | 80863 | 0.050 |
Why?
|
| Survival Rate | 7 | 2015 | 12875 | 0.050 |
Why?
|
| DNA, Neoplasm | 4 | 2001 | 1749 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2009 | 1814 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2006 | 439 | 0.050 |
Why?
|
| Amino Acid Substitution | 4 | 2016 | 1744 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1992 | 2568 | 0.050 |
Why?
|
| Nevus | 1 | 2005 | 206 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2013 | 4029 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2004 | 545 | 0.050 |
Why?
|
| Metaplasia | 1 | 2004 | 326 | 0.050 |
Why?
|
| Piperazines | 3 | 2016 | 2546 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2007 | 1221 | 0.050 |
Why?
|
| Thymus Neoplasms | 1 | 2005 | 278 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.050 |
Why?
|
| G1 Phase | 3 | 2009 | 404 | 0.050 |
Why?
|
| Jurkat Cells | 3 | 2012 | 743 | 0.050 |
Why?
|
| Aged | 18 | 2017 | 171520 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2015 | 452 | 0.050 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2007 | 489 | 0.050 |
Why?
|
| Fluorouracil | 3 | 2014 | 1656 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2002 | 431 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 2008 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2015 | 3635 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2003 | 264 | 0.050 |
Why?
|
| Exons | 1 | 2008 | 2392 | 0.050 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2002 | 111 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 2004 | 867 | 0.050 |
Why?
|
| Ligases | 1 | 2003 | 333 | 0.050 |
Why?
|
| Binding, Competitive | 3 | 2010 | 1144 | 0.050 |
Why?
|
| Adult | 21 | 2017 | 223542 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2016 | 3523 | 0.050 |
Why?
|
| Acetylation | 2 | 2016 | 1053 | 0.050 |
Why?
|
| Radiation Chimera | 3 | 2009 | 216 | 0.050 |
Why?
|
| Receptors, LDL | 2 | 2015 | 491 | 0.050 |
Why?
|
| Bone Marrow Purging | 2 | 1998 | 108 | 0.050 |
Why?
|
| Disulfides | 2 | 2003 | 467 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 18048 | 0.050 |
Why?
|
| Integrins | 1 | 2005 | 845 | 0.050 |
Why?
|
| Antibodies, Viral | 2 | 2010 | 3212 | 0.050 |
Why?
|
| Prognosis | 7 | 2017 | 30028 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2014 | 2184 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2014 | 2072 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 1290 | 0.040 |
Why?
|
| Adolescent | 9 | 2017 | 89168 | 0.040 |
Why?
|
| Peptide Fragments | 4 | 2000 | 5152 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3826 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 4642 | 0.040 |
Why?
|
| Receptor, trkC | 1 | 2000 | 63 | 0.040 |
Why?
|
| Furin | 2 | 2011 | 46 | 0.040 |
Why?
|
| Nurses | 1 | 2010 | 2494 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2000 | 38 | 0.040 |
Why?
|
| Antigens, CD34 | 2 | 2017 | 656 | 0.040 |
Why?
|
| Calmodulin | 4 | 1982 | 241 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 3 | 2011 | 314 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2003 | 538 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2000 | 179 | 0.040 |
Why?
|
| Genomics | 4 | 2018 | 5909 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2010 | 808 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2006 | 1503 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 254 | 0.040 |
Why?
|
| Cattle | 4 | 1986 | 3830 | 0.040 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 1770 | 0.040 |
Why?
|
| Genes, ras | 2 | 2014 | 666 | 0.040 |
Why?
|
| Ion Transport | 1 | 2000 | 322 | 0.040 |
Why?
|
| Cross Reactions | 3 | 1986 | 828 | 0.040 |
Why?
|
| Tyrosine | 2 | 2000 | 1428 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2005 | 1375 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 456 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2016 | 10125 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2012 | 3431 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1608 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2005 | 1797 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 2000 | 313 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1990 | 2254 | 0.040 |
Why?
|
| Doxorubicin | 4 | 2015 | 2229 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2003 | 843 | 0.040 |
Why?
|
| Transformation, Genetic | 2 | 1998 | 194 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2000 | 577 | 0.040 |
Why?
|
| Genes, Insect | 2 | 2000 | 265 | 0.040 |
Why?
|
| Species Specificity | 3 | 2000 | 2422 | 0.040 |
Why?
|
| Tuberculosis | 1 | 1990 | 2030 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1984 | 1734 | 0.040 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 42 | 0.040 |
Why?
|
| Codon, Nonsense | 2 | 2011 | 287 | 0.040 |
Why?
|
| HIV Seronegativity | 1 | 1998 | 211 | 0.040 |
Why?
|
| Ear, Inner | 1 | 2001 | 426 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2014 | 647 | 0.040 |
Why?
|
| Cell Transformation, Viral | 3 | 2006 | 530 | 0.040 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 108 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2016 | 3615 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.040 |
Why?
|
| ras Proteins | 1 | 2002 | 1058 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2018 | 162 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2007 | 3794 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1996 | 310 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2001 | 879 | 0.030 |
Why?
|
| Lung | 2 | 2006 | 10090 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 1706 | 0.030 |
Why?
|
| Receptors, CXCR4 | 2 | 2015 | 729 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1997 | 383 | 0.030 |
Why?
|
| Subrenal Capsule Assay | 1 | 2016 | 27 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2004 | 1840 | 0.030 |
Why?
|
| Virus Integration | 4 | 2000 | 306 | 0.030 |
Why?
|
| HL-60 Cells | 2 | 2012 | 364 | 0.030 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 2393 | 0.030 |
Why?
|
| Epitopes | 2 | 2016 | 2526 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 229 | 0.030 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 168 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 288 | 0.030 |
Why?
|
| Blood Platelet Disorders | 1 | 1996 | 60 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2014 | 12774 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1998 | 577 | 0.030 |
Why?
|
| Artificial Cells | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2016 | 182 | 0.030 |
Why?
|
| Lod Score | 2 | 2011 | 600 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 1223 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 1997 | 6091 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 3 | 1 | 2014 | 10 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2017 | 890 | 0.030 |
Why?
|
| Ankyrins | 2 | 2007 | 123 | 0.030 |
Why?
|
| Genome, Viral | 2 | 2011 | 673 | 0.030 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 25 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 3 | 2000 | 268 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2014 | 49 | 0.030 |
Why?
|
| Glycosylation | 2 | 2011 | 1100 | 0.030 |
Why?
|
| CHO Cells | 3 | 2003 | 1382 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2015 | 252 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4622 | 0.030 |
Why?
|
| Fetal Stem Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 13589 | 0.030 |
Why?
|
| Codon | 1 | 2016 | 599 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2008 | 42623 | 0.030 |
Why?
|
| Thiadiazoles | 1 | 2014 | 63 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2000 | 1115 | 0.030 |
Why?
|
| Benzamides | 2 | 2014 | 1381 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2016 | 370 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 195 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 1077 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 322 | 0.030 |
Why?
|
| Biopsy | 2 | 2017 | 6816 | 0.030 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 354 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 510 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1232 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 424 | 0.030 |
Why?
|
| DNA | 5 | 2007 | 7213 | 0.030 |
Why?
|
| Combined Modality Therapy | 4 | 1999 | 8559 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2015 | 239 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 369 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1996 | 249 | 0.030 |
Why?
|
| Protons | 1 | 1999 | 1113 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 716 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 60045 | 0.030 |
Why?
|
| Cricetinae | 3 | 2003 | 2423 | 0.030 |
Why?
|
| Enzyme Activation | 3 | 2005 | 3594 | 0.030 |
Why?
|
| K562 Cells | 1 | 2015 | 645 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2014 | 22293 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1994 | 527 | 0.030 |
Why?
|
| Safety | 1 | 2017 | 1159 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2017 | 1438 | 0.030 |
Why?
|
| Hyperplasia | 2 | 1995 | 1154 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 2012 | 148 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1986 | 2173 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1995 | 259 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20231 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4780 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 2 | 2007 | 910 | 0.030 |
Why?
|
| Software | 2 | 2018 | 4463 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2014 | 423 | 0.030 |
Why?
|
| Gene Transfer Techniques | 3 | 2004 | 1209 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 738 | 0.020 |
Why?
|
| Disease Progression | 2 | 2011 | 13655 | 0.020 |
Why?
|
| Lysine | 1 | 2016 | 989 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1992 | 417 | 0.020 |
Why?
|
| Acute Disease | 4 | 2008 | 7246 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2015 | 3713 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 208 | 0.020 |
Why?
|
| Azepines | 1 | 2014 | 329 | 0.020 |
Why?
|
| Vincristine | 3 | 2002 | 1039 | 0.020 |
Why?
|
| S Phase | 2 | 2008 | 425 | 0.020 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2011 | 25 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2399 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 639 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 418 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 293 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 703 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2011 | 61 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2015 | 943 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2015 | 3586 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2004 | 545 | 0.020 |
Why?
|
| Immune System | 1 | 2016 | 801 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2003 | 4175 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1688 | 0.020 |
Why?
|
| Skin | 3 | 2014 | 4520 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2238 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 808 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 2006 | 1435 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 1990 | 92 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2011 | 118 | 0.020 |
Why?
|
| Endocytosis | 1 | 2015 | 960 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 706 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2017 | 5709 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 583 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2011 | 169 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 899 | 0.020 |
Why?
|
| Rabbits | 2 | 2009 | 4786 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1104 | 0.020 |
Why?
|
| Glycosyltransferases | 1 | 2011 | 114 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 166 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1994 | 965 | 0.020 |
Why?
|
| Genome | 2 | 2009 | 1749 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 254 | 0.020 |
Why?
|
| RNA, Neoplasm | 2 | 2008 | 751 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1064 | 0.020 |
Why?
|
| COS Cells | 2 | 2003 | 1136 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 542 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 507 | 0.020 |
Why?
|
| Erythropoietin | 1 | 1994 | 719 | 0.020 |
Why?
|
| Gene Expression | 4 | 2006 | 7605 | 0.020 |
Why?
|
| Recurrence | 3 | 2007 | 8510 | 0.020 |
Why?
|
| Cell Membrane Permeability | 2 | 2009 | 574 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 607 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4041 | 0.020 |
Why?
|
| Cytogenetics | 1 | 2010 | 198 | 0.020 |
Why?
|
| Prednisone | 3 | 2002 | 1568 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 2 | 2000 | 352 | 0.020 |
Why?
|
| Thrombopoiesis | 1 | 2011 | 167 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1750 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2005 | 1906 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2009 | 2067 | 0.020 |
Why?
|
| Adenine | 1 | 2015 | 993 | 0.020 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2009 | 25 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1909 | 0.020 |
Why?
|
| Calcium Channels | 1 | 2013 | 624 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 1494 | 0.020 |
Why?
|
| Stem Cells | 3 | 2011 | 3538 | 0.020 |
Why?
|
| Dogs | 2 | 1984 | 3847 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2015 | 1532 | 0.020 |
Why?
|
| Morphogenesis | 2 | 2004 | 747 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1977 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1999 | 3783 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 418 | 0.020 |
Why?
|
| Lymph Nodes | 2 | 2017 | 3472 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 419 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2015 | 1415 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2009 | 1489 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 547 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 905 | 0.020 |
Why?
|
| Cyclophosphamide | 3 | 2002 | 2224 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2009 | 455 | 0.020 |
Why?
|
| Insecticides | 1 | 2010 | 200 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 654 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 1993 | 1032 | 0.020 |
Why?
|
| Treatment Outcome | 5 | 2018 | 65409 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2003 | 835 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2006 | 2731 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 482 | 0.020 |
Why?
|
| Trisomy | 1 | 1989 | 261 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2000 | 259 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14728 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2012 | 577 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 727 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2009 | 296 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 532 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 489 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1992 | 1390 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 2007 | 32 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 746 | 0.020 |
Why?
|
| Inflammation | 1 | 2007 | 10865 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 940 | 0.020 |
Why?
|
| Dopa Decarboxylase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Syndrome | 3 | 2000 | 3278 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 617 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2002 | 2659 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1684 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2010 | 469 | 0.020 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2006 | 36 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6320 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2001 | 648 | 0.020 |
Why?
|
| Glutathione Transferase | 2 | 2003 | 567 | 0.020 |
Why?
|
| Erythrocytes | 3 | 1982 | 2422 | 0.020 |
Why?
|
| Coculture Techniques | 2 | 2003 | 1343 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1892 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3816 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.020 |
Why?
|
| Piperidines | 1 | 2015 | 1664 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2006 | 122 | 0.020 |
Why?
|
| Ploidies | 1 | 2007 | 287 | 0.020 |
Why?
|
| DNA Replication | 1 | 1993 | 1428 | 0.020 |
Why?
|
| Organ Specificity | 2 | 2004 | 1972 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1881 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 776 | 0.020 |
Why?
|
| RNA | 2 | 2006 | 2727 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 1026 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 873 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1855 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2007 | 319 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 520 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1775 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2465 | 0.020 |
Why?
|
| Calcitonin | 1 | 2006 | 329 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 399 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1985 | 116 | 0.020 |
Why?
|
| Adipocytes | 1 | 2012 | 1199 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1985 | 175 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 673 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2004 | 3664 | 0.020 |
Why?
|
| Reed-Sternberg Cells | 1 | 2005 | 78 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2006 | 213 | 0.010 |
Why?
|
| Leukoplakia, Hairy | 1 | 2004 | 10 | 0.010 |
Why?
|
| DNA, Viral | 2 | 2004 | 2206 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6856 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 478 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3939 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 420 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2932 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2007 | 317 | 0.010 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 480 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2007 | 556 | 0.010 |
Why?
|
| Autoradiography | 1 | 1985 | 732 | 0.010 |
Why?
|
| Contactins | 1 | 2003 | 21 | 0.010 |
Why?
|
| Immunocompetence | 1 | 2004 | 139 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2006 | 594 | 0.010 |
Why?
|
| Up-Regulation | 2 | 2003 | 4138 | 0.010 |
Why?
|
| Biotinylation | 1 | 2004 | 185 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 462 | 0.010 |
Why?
|
| Immune Sera | 1 | 1984 | 605 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 530 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3123 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2003 | 110 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2004 | 425 | 0.010 |
Why?
|
| Calorimetry | 1 | 2003 | 132 | 0.010 |
Why?
|
| Mosaicism | 1 | 2007 | 481 | 0.010 |
Why?
|
| Kinetics | 1 | 2011 | 6348 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3103 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2015 | 54914 | 0.010 |
Why?
|
| Myeloid Cells | 1 | 2008 | 833 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 47 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2006 | 549 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 13047 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1999 | 8051 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2008 | 1335 | 0.010 |
Why?
|
| Static Electricity | 1 | 2003 | 261 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2008 | 1165 | 0.010 |
Why?
|
| DNA Damage | 1 | 2012 | 2461 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2006 | 812 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 501 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2006 | 598 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 899 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 511 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 930 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1738 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 463 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1990 | 1390 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 343 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 432 | 0.010 |
Why?
|
| Homozygote | 1 | 2007 | 1779 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2006 | 4180 | 0.010 |
Why?
|
| Olfactory Bulb | 1 | 2003 | 198 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 828 | 0.010 |
Why?
|
| Biophysics | 1 | 2003 | 379 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1982 | 197 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2010 | 41797 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2565 | 0.010 |
Why?
|
| Melanocytes | 1 | 2005 | 512 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2003 | 392 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 640 | 0.010 |
Why?
|
| Viremia | 1 | 2004 | 725 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1984 | 708 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2696 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1985 | 1468 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 906 | 0.010 |
Why?
|
| Oncostatin M | 1 | 2000 | 42 | 0.010 |
Why?
|
| Electroporation | 1 | 2001 | 236 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2016 | 4728 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2000 | 100 | 0.010 |
Why?
|
| Women's Health | 1 | 2010 | 2079 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1989 | 1422 | 0.010 |
Why?
|
| Risk Factors | 4 | 2010 | 74915 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 381 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2012 | 3335 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6217 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2000 | 111 | 0.010 |
Why?
|
| Epithelium | 1 | 1984 | 1610 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3080 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 2792 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2000 | 131 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 1098 | 0.010 |
Why?
|
| Leukopoiesis | 1 | 1999 | 54 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 564 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3417 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2000 | 287 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 458 | 0.010 |
Why?
|
| Transgenes | 1 | 2003 | 1015 | 0.010 |
Why?
|
| Tissue Transplantation | 1 | 2000 | 128 | 0.010 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1999 | 24 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 682 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 875 | 0.010 |
Why?
|
| Pyridines | 1 | 2011 | 2888 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10358 | 0.010 |
Why?
|
| Genes, abl | 1 | 1998 | 69 | 0.010 |
Why?
|
| Genetic Markers | 2 | 1996 | 2604 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11249 | 0.010 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1998 | 53 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1982 | 633 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1999 | 138 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3442 | 0.010 |
Why?
|
| Blast Crisis | 1 | 1998 | 102 | 0.010 |
Why?
|
| Infant | 3 | 2006 | 36497 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2012 | 3974 | 0.010 |
Why?
|
| Zinc | 2 | 1981 | 677 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1998 | 455 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2003 | 1078 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 2459 | 0.010 |
Why?
|
| Splenomegaly | 1 | 1998 | 192 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 2596 | 0.010 |
Why?
|
| Genes | 1 | 2001 | 1824 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9687 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 2002 | 505 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.010 |
Why?
|
| Granulocytes | 1 | 1999 | 550 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 23839 | 0.010 |
Why?
|
| Liver | 2 | 2004 | 7575 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1998 | 425 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1755 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6657 | 0.010 |
Why?
|
| Virus Latency | 1 | 2000 | 360 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1706 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 2298 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 1230 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1996 | 110 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1996 | 249 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1996 | 363 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 2865 | 0.010 |
Why?
|
| Kidney | 2 | 2003 | 7064 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6242 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2000 | 1685 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 13324 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 4362 | 0.010 |
Why?
|
| Mitoxantrone | 1 | 1995 | 148 | 0.010 |
Why?
|
| Daunorubicin | 1 | 1995 | 157 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1297 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 3399 | 0.010 |
Why?
|
| Ifosfamide | 1 | 1995 | 234 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 7449 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 781 | 0.010 |
Why?
|
| Whole-Body Irradiation | 1 | 1994 | 434 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 1725 | 0.010 |
Why?
|
| Hydroxyurea | 1 | 1995 | 284 | 0.010 |
Why?
|
| Replication Protein A | 1 | 1993 | 54 | 0.010 |
Why?
|
| Etoposide | 1 | 1995 | 640 | 0.010 |
Why?
|
| Fibrosis | 1 | 2000 | 2076 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18478 | 0.010 |
Why?
|
| Cytarabine | 1 | 1995 | 697 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1993 | 257 | 0.010 |
Why?
|
| Muscles | 1 | 1997 | 1582 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 1997 | 1014 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 1981 | 1065 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1999 | 1353 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4425 | 0.010 |
Why?
|
| Carboplatin | 1 | 1995 | 798 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1989 | 6400 | 0.010 |
Why?
|
| Glutathione | 1 | 1993 | 587 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1995 | 1840 | 0.010 |
Why?
|
| Microspheres | 1 | 1993 | 789 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2002 | 2040 | 0.010 |
Why?
|
| Haplotypes | 1 | 1996 | 2725 | 0.010 |
Why?
|
| Brain | 1 | 2016 | 27438 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 1997 | 4834 | 0.000 |
Why?
|
| Pedigree | 1 | 1996 | 4545 | 0.000 |
Why?
|
| Pregnancy | 2 | 2004 | 30179 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 16029 | 0.000 |
Why?
|
| Gestational Age | 1 | 1996 | 3615 | 0.000 |
Why?
|
| Karyotyping | 1 | 1989 | 1173 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 4984 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26395 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 2680 | 0.000 |
Why?
|
| Calcimycin | 1 | 1982 | 214 | 0.000 |
Why?
|
| United States | 1 | 2010 | 73121 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1982 | 238 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1993 | 4220 | 0.000 |
Why?
|
| Connexins | 1 | 1982 | 355 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 3861 | 0.000 |
Why?
|
| Chickens | 1 | 1982 | 860 | 0.000 |
Why?
|
| Edetic Acid | 1 | 1979 | 278 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2000 | 8721 | 0.000 |
Why?
|
| Retrospective Studies | 2 | 1998 | 81834 | 0.000 |
Why?
|
| Hemolysis | 1 | 1979 | 419 | 0.000 |
Why?
|
| Incidence | 1 | 1994 | 21552 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 21156 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1979 | 842 | 0.000 |
Why?
|
| Anesthetics, Local | 1 | 1981 | 1005 | 0.000 |
Why?
|
| Antipsychotic Agents | 1 | 1981 | 3077 | 0.000 |
Why?
|